Your browser doesn't support javascript.
loading
Blood Transcriptomes of SARS-CoV-2-Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity.
Sun, Zeguo; Zhang, Zhongyang; Banu, Khadija; Azzi, Yorg Al; Reghuvaran, Anand; Fredericks, Samuel; Planoutene, Marina; Hartzell, Susan; Kim, Yesl; Pell, John; Tietjen, Gregory; Asch, William; Kulkarni, Sanjay; Formica, Richard; Rana, Meenakshi; Maltzman, Jonathan S; Zhang, Weijia; Akalin, Enver; Heeger, Peter S; Cravedi, Paolo; Menon, Madhav C.
Affiliation
  • Sun Z; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Zhang Z; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Banu K; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Azzi YA; Division of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Reghuvaran A; Montefiore Einstein Center for Transplantation, Albert Einstein College of Medicine, Bronx, New York.
  • Fredericks S; Division of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Planoutene M; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Hartzell S; Division of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Kim Y; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Pell J; Geriatric Research Education and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
  • Tietjen G; Division of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Asch W; Department of Surgery, Yale University school of Medicine, New Haven, Connecticut.
  • Kulkarni S; Division of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Formica R; Department of Surgery, Yale University school of Medicine, New Haven, Connecticut.
  • Rana M; Division of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Maltzman JS; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Zhang W; Geriatric Research Education and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
  • Akalin E; Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California.
  • Heeger PS; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Cravedi P; Montefiore Einstein Center for Transplantation, Albert Einstein College of Medicine, Bronx, New York.
  • Menon MC; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
J Am Soc Nephrol ; 33(11): 2108-2122, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36041788
BACKGROUND: Among patients with COVID-19, kidney transplant recipients (KTRs) have poor outcomes compared with non-KTRs. To provide insight into management of immunosuppression during acute illness, we studied immune signatures from the peripheral blood during and after COVID-19 infection from a multicenter KTR cohort. METHODS: We ascertained clinical data by chart review. A single sample of blood was collected for transcriptome analysis. Total RNA was poly-A selected and RNA was sequenced to evaluate transcriptome changes. We also measured cytokines and chemokines of serum samples collected during acute infection. RESULTS: A total of 64 patients with COVID-19 in KTRs were enrolled, including 31 with acute COVID-19 (<4 weeks from diagnosis) and 33 with post-acute COVID-19 (>4 weeks postdiagnosis). In the blood transcriptome of acute cases, we identified genes in positive or negative association with COVID-19 severity scores. Functional enrichment analyses showed upregulation of neutrophil and innate immune pathways but downregulation of T cell and adaptive immune activation pathways. This finding was independent of lymphocyte count, despite reduced immunosuppressant use in most KTRs. Compared with acute cases, post-acute cases showed "normalization" of these enriched pathways after 4 weeks, suggesting recovery of adaptive immune system activation despite reinstitution of immunosuppression. Analysis of the non-KTR cohort with COVID-19 showed significant overlap with KTRs in these functions. Serum inflammatory cytokines followed an opposite trend (i.e., increased with disease severity), indicating that blood lymphocytes are not the primary source. CONCLUSIONS: The blood transcriptome of KTRs affected by COVID-19 shows decreases in T cell and adaptive immune activation pathways during acute disease that, despite reduced immunosuppressant use, associate with severity. These pathways show recovery after acute illness.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2022 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2022 Document type: Article Country of publication: United States